Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome

Table 1 Body weight parameters: Baseline[24]

	BMI (kg/m2)	Body weight (kg)	WC (cm)
Metformin	36.6 ± 3.5	103.2 ± 6.3	122.3 ± 7.0
Liraglutide	39.3 ± 4.2	108.9 ± 15.1	124.9 ± 9.9
COMBI	37.6 ± 5.1	105.5 ± 20.6	121.9 ± 17.7

COMBI: Combination of liraglutide and metformin; WC: Waist circumference; BMI: Body mass index.

Table 2 Post-treatment (3-mo) body weight parameters[24]

	BMI (kg/m2)	Body weight (kg)	WC (cm)
Metformin	36.1 ± 3.8	102 ± 6.8	120.7 ± 7.8
Liraglutide	37.6 ± 5.1	105.1 ± 13.8	121.7 ± 9.6
COMBI	35.5 ± 5.5	99.0 ± 21.2	116.4 ± 18.4

COMBI: Combination of liraglutide and metformin; WC: Waist circumference; BMI: Body mass index.